Benjamin Wolin joins the board of Dance Biopharm

Inhaled insulin developer Dance Biopharm has announced that Diplomat Specialty Pharmacy Chairman Benjamin Wolin has joined its board of directors. In 2002, Wolin co-founded digital marketing company Everyday Health and led the company until its acquisition by Ziff Davis in 2016.

In December 2017, Dance announced that it had partnered with Phillips-Medisize for development of a connected version of Dance’s Dance 501 insulin soft mist inhaler device.

Dance Biopharm Chairman and CEO John Patton said, “Adding Ben to the Board of Directors is an important step forward for Dance. Ben is a proven executive who has deep experience in digital health, pharma marketing and commercialization as well as IPO and public board successes. His background and enthusiasm for our opportunity will be invaluable as we continue to develop our transformative product — position it for commercial success — and build a leading franchise in the diabetes category.”

Wolin commented, “John and the rest of the Dance team have created an amazing opportunity to both build a significant business and help millions of patients manage their diabetes without the pain and frustration of daily injections. I am thrilled to join the Board of Directors in order to help Dance succeed and fulfill its fantastic mission.”

Read the Dance Biopharm press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan